Skip to content
AI IntelligenceJun 18, 2026Primary Market
Article

Faeth Therapeutics, Inc. · Not disclosed · Unbekannt

Faeth Therapeutics has entered into a material definitive agreement, suggesting a funding round. The company focuses on therapeutic nutrition for cancer treatment.

Data Cube AI EditorialSource: SEC EDGAR
01

Source Brief

Faeth Therapeutics has entered into a material definitive agreement, suggesting a funding round. The company focuses on therapeutic nutrition for cancer treatment.